iRhythm Completes Acquisition of VitalConnect
iRhythm completed the acquisition of VitalConnect to expand its cardiac monitoring portfolio across the continuum of care. This strategic M&A deal is expected to accelerate revenue growth beginning in 2027 while maintaining a 15% adjusted EBITDA margin target.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
START FREE — 10,000 calls/day, no key needed